HIGHLIGHTS
- who: Xiaoling Li from the (UNIVERSITY) have published the research: Role of Rho GTPases in inflammatory bowel disease, in the Journal: (JOURNAL) of 11/01/2023
- what: Accumulating evidence has revealed that Rho GTPases are associated with IBD pathogenesis.
- future: New drug discovery and fewer adverse reactions are future research directions for therapies targeting Rho GTPases. Rho GTPases are associated with the pathogenesis of IBD and further clinical studies are required to confirm and explore the underlying mechanisms. The Clinical Prospect of Rho GTPases is promising and require further studies on safety improvements . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.